It's not reasonable for every decision to be referred to court though and the proposed process includes MH professionals and will be a lot more open than previous practice.
As an interim measure, and in direct response to the Court’s suggestion that additional safeguards may be warranted, a new independent multidisciplinary professional review group will be established to confirm decision-making has followed a robust process.
This group will be comprised of health and care professionals with expertise in child development, neurodevelopment and mental health, assessing capacity and consent, and safeguarding processes. The review group will ensure:
the Tavistock’s GIDS has carried out an enhanced clinical review of each patient;
there has been a robust process for providing parental consent and child assent;
adequate information, including on the risks and benefits of puberty blockers and on the limited available evidence such that the court has described the treatment as ‘experimental’, has been provided to both patient and parent(s);
the clinical process for forming a prescribing recommendation followed good practice guidelines;
any relevant needs of the patient, and what this may mean for their wider healthcare, has been fully explored.
I think we can assume this will be monitored very carefully with outcomes tracked too.